Fredrik Lindberg

Chromatin, Inc. provides seed and feedstock products for traditional agriculture and bio-industrial processes. The firm markets seed products under its Sorghum Partners brand, primarily the grain sorghum and forage sorghum seed types. It also delivers sorghum products for companies seeking renewable feedstock. Its service areas encompass supplying seed, contracting growers, providing agronomic support, and overseeing harvest and delivery of feedstock in the form and specifications required by bio-processors. The company was founded by Kevin Keith, Daphne Preuss and Gregory Paul Copenhaver in 2001 and is headquartered in Chicago, IL.

Feldman & Associates provides accounting services. The private company is based in Toronto, Canada. and has subsidiaries in Canada. Izzy Feldman has been the CEO of the Canadian company since 2010.

First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL.

Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million.

Evanston Partners LLC (Evanston Partners) is a private equity firm founded in 1900. The firm is headquartered in Evanston, Illinois.

Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022.

Electrochaea LLC develops technology for converting electricity and carbon dioxide into methane. Its technology enables to store renewable energy from wind and solar and represents a viable solution for utility-scale energy storage, grid balancing and carbon recycling. The company was founded in 2009 and is headquartered in St. Louis, MO.

BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden.

AM e-Consulting AB provides independent medical second opinion services. It offers second opinion to all medical areas except psychiatry. The company was founded by Lars Ake Alvar Lidgren, Leif Granath and Kjell Ingemar Ihse in 2004 and is headquartered in Stockholm, Sweden.

Ortopedservice i Stockholm Ortopedingenjören AB provides a range of orthopedic products like foot beds, bandages, and other rehabilitation products and medical pedicure. The firm manufactures product for musculoskeletal disorders. It sells shoes and casual shoes; boots; Running shoes; sandals; sport protection; socks; accessories; and walking shoes. The company was founded by Carl Wiklund in 1995 and is headquartered in Stockholm, Sweden.

Chicago Capital Partners Management LLC (Chicago Capital Partners) is a private equity subsidiary of Kovitz Investment Group LLC founded in 2011. The firm is headquartered in Highland Park, Illinois.

Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland.

Lakartid Nu Nordic AB operates a hospital.

Oberoende Forsakringar I Sverige AB provides insurance services. The private company is based in Sweden.

Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland.

Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies.

Acadian Kitchens LLC is a company that specializes in providing authentic Cajun and Creole cuisine to customers. The company is based in Broussard, LA and has subsidiaries in the United States. The company believes in delivering mouth-watering and exciting American cuisine choices to everyone. The CEO of the company is Paul Leleux.

213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois.

Moroxite AB is a medtech company based in Lund, Sweden, with subsidiaries in Sweden. Moroxite is developing a portfolio of breakthrough therapies in targeted drug delivery, using innovative nano and micro technology-based platforms. The Swedish company's focus areas include bone regeneration, tumor, and bone infection. The private company has developed a platform for prolonged release of apatite binding drugs, using a carrier containing nano and micro particles. Recently, Moroxite spun-off its bone infection and fracture fixation businesses into independent companies, Moroxite I AB and Moroxite F AB, respectively. Moroxite F AB has raised capital of 10 MSEK in a private placement from two investors, Fåhraeus Startup & Growth and Almi Invest. The company was founded in 2020 by Lars Ã…ke Alvar Lidgren, Magnus Tägil, and Deepak Raina.